pharmacoeconomic - Globe Thesis

Keyword [pharmacoeconomic] Result: 41 - 60 \| Page: 3 of 4
41.	Pharmacoeconomic analysis of antihypertensive treatment in a population with type 2 diabetes
42.	Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: A pharmacoeconomic analysis employing a net -benefit regression method of cost -effectiveness
43.	Clinical Pharmacology of Oral Anticoagulants: Pharmacoepidemiology, Safety and Pharmacoeconomic
44.	Use of pharmacoeconomic data for formulary decision making in teaching hospitals
45.	Cost Effectiveness Analysis Of New Pharmacoeconomic Evaluation Method Based On Bayesian Inference For The Treatment Of Chronic Obstructive Pulmonary Disease
46.	Clinical Efficacy And Pharmacoeconomic Analysis Of Acute Lymphoblastic Leukemia In The Era Of DRG
47.	Treating Advanced Non-small Cell Lung Cancer Patients With Immune Checkpoint Inhibitors: A Pharmacoeconomic Research
48.	Pharmacoeconomic Evaluation Of Camrelizumab Plus Chemotherapy In First-line Treatment Of Advanced Non-squamous Non-small-cell Lung Cancer
49.	Methodological Research On Pharmacoeconomic Evaluation Of Gastrointestinal Cancer Based On RWD
50.	The Clinical Evaluation Of Warfarin And Its Pharmacoeconomic Evaluation With Rivaroxaban
51.	Pharmacoeconomic Evaluation Of Rosuvastatin In Primary Prevention Of Cardiovascular Disease
52.	Clinical Research And Pharmacoeconomic Evaluation Of Huoxue Huatan Xifeng Decoction For Patients With Acute Cerebral Infarctio (With The Syndrome Of Wind-phlegm Stasis)
53.	Pharmacoeconomic Analysis Of Rivaroxaban And Warfarin For Stroke Prevention And Treatment In Patients With Atrial Fibrillation
54.	Pharmacoeconomic Evaluation Of Decompensated Chronic Hepatitis B Fibrosis Based On Net Benefit Regression Framework
55.	Pharmacoeconomic Evaluation Of Immunotherapy Combined With Chemotherapy For Lung Cancer And Esophageal Carcinoma
56.	The Impact On Disease Management And Economic Benefit Of Medication Therapy Management In Patients With Chronic Obstructive Pulmonary Disease
57.	Pharmacoeconomic Evaluation Of Hypertension Drugs Based On Markov Model
58.	Clinical Pharmacoeconomic Evaluation Of Levosimendan And Milrinone In The Treatment Of Severe Heart Failure
59.	The Standardization For Health State Utility Values Applied In Pharmacoeconomic Evaluation Models
60.	Pharmacoeconomic Evaluation Of DNF-N Vs. DPF-P In The Treatment Of Locally Advanced Nasopharyngeal Carcinoma By Markov Model
<<First <Prev Next> Last>> Jump to